Curie-Cancer is built on the expertise of Institut Curie  

(with 3200 people), a leading comprehensive cancer center  

in Europe and a world-renowned hospital.

Curie-Cancer offers industrial partners the possibility to  

set-up research collaborations from early discovery 

(cognitive research) to most advanced research (clinical 

research).

From therapeutic target… to clinical validation

Target markets

• 

Health

• 

Cosmetics

Examples of collaborative 

projects with industrial partners 

 Identification and validation 

of therapeutic targets 

 Evaluation of drug efficiency 

and antitumor activity on 

human xenograft mice

 Identification of biomarkers
 Identification of the mechanism 

of actions for drug in development 

 Medicinal chemistry
 Design of monoclonal antibodies 

against therapeutic targets

 Pharmacokinetic 
 Clinical studies in phase I,  

II or III in several cancer indications 

The model of Marie Curie

 Marie Curie, founder of Institut 

Curie, was attached to the continuum 

between fundamental research, clinical 

research and patient care. Curie Cancer 

carries these dynamics and puts 

together leading teams from cognitive 

to translational and clinical research.

 Curie-Cancer is offering to industrial 

partners, tailor-made collaborative 

research projects, based on the 

internal expertise of its teams as well 

as advanced technical platforms.

 Curie-Cancer is led by professionals 

with extensive experience in the 

pharmaceutical industry and/

or biotechnology sector, thus 

setting-up efficient collaborations 

with its industrial partners.

http://curie.fr/fr/curie-cancer

© Noak / Le Bar Floréal / Institut Curie

© Pedro Lombardi / Institut Curie